Dual Immunotherapy Shows Activity in Clear Cell Gynecologic Cancers

By News Health
4 weeks Ago

(MedPage Today) — Nivolumab (Opdivo) plus ipilimumab (Yervoy) showed significant activity in patients with advanced gynecologic clear cell carcinomas, according to results from a phase II nonrandomized trial.
Among 26 evaluable patients with…

Source link : https://www.medpagetoday.com/hematologyoncology/ovariancancer/116371

Author :

Publish date : 2025-07-03 15:00:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Preterm Birth Predicts Adult Health Problems

Refine Your Application as Residency Deadline Approaches

How Safe Is Robotic Surgery?

JAK Inhibitors Raise Venous Thromboembolism Risk in AD

Here's Who Made This Year's List of Top Hospitals

At Least 60% of Liver Cancers Tied to Preventable Risk Factors